Cargando…

T Cells Enhance Stem-Like Properties and Conditional Malignancy in Gliomas

BACKGROUND: Small populations of highly tumorigenic stem-like cells (cancer stem cells; CSCs) can exist within, and uniquely regenerate cancers including malignant brain tumors (gliomas). Many aspects of glioma CSCs (GSCs), however, have been characterized in non-physiological settings. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Irvin, Dwain K., Jouanneau, Emmanuel, Duvall, Gretchen, Zhang, Xiao-xue, Zhai, Yuying, Sarayba, Danielle, Seksenyan, Akop, Panwar, Akanksha, Black, Keith L., Wheeler, Christopher J.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881867/ https://www.ncbi.nlm.nih.gov/pubmed/20539758 http://dx.doi.org/10.1371/journal.pone.0010974

Ejemplares similares

T-Lymphocyte Deficiency Exacerbates Behavioral Deficits in the 6-OHDA Unilateral Lesion Rat Model for Parkinson’s Disease
por: Wheeler, Christopher J, et al.
Publicado: (2014)

CD103 Deficiency Promotes Autism (ASD) and Attention-Deficit Hyperactivity Disorder (ADHD) Behavioral Spectra and Reduces Age-Related Cognitive Decline
por: Jhun, Michelle, et al.
Publicado: (2020)

Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1
por: Cordner, Ryan, et al.
Publicado: (2023)

Abnormal Changes in NKT Cells, the IGF-1 Axis, and Liver Pathology in an Animal Model of ALS
por: Finkelstein, Arseny, et al.
Publicado: (2011)

Functional recreation of age-related CD8 T cells in young mice identifies drivers of aging- and human-specific tissue pathology
por: Panwar, Akanksha, et al.
Publicado: (2020)

TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer
por: Seksenyan, Akop, et al.
Publicado: (2015)

Analysis of gene expression and chemoresistance of CD133(+ )cancer stem cells in glioblastoma
por: Liu, Gentao, et al.
Publicado: (2006)

Cluster-like headache: literature review
por: Giraud, Pierric, et al.
Publicado: (2002)

Magnetic kyphoplasty: A novel drug delivery system for the spinal column
por: Denyer, Steven, et al.
Publicado: (2018)

Conditional Astroglial Rictor Overexpression Induces Malignant Glioma in Mice
por: Bashir, Tariq, et al.
Publicado: (2012)

Antigen-armed antibodies against B-cell malignancies
por: Ilecka, Marta, et al.
Publicado: (2018)

Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis
por: Seksenyan, Akop, et al.
Publicado: (2010)

Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines
por: Rahman, Maryam, et al.
Publicado: (2015)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

Immunotherapy for malignant glioma
por: Suryadevara, Carter M., et al.
Publicado: (2015)

Immunotherapies for Malignant Glioma
por: Boussiotis, Vassiliki A., et al.
Publicado: (2017)

Elastin-like Polypeptide Hydrogels for Tunable, Sustained Local Chemotherapy in Malignant Glioma
por: Dragojevic, Sonja, et al.
Publicado: (2022)

Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model
por: Hu, Jinwei, et al.
Publicado: (2007)

Self-reported recognition of undiagnosed life threatening conditions in chiropractic practice: a random survey
por: Daniel, Dwain M, et al.
Publicado: (2012)

Glioma Stem Cells and Immunotherapy for the Treatment of Malignant Gliomas
por: Toda, Masahiro
Publicado: (2013)

Association of Notch-1, osteopontin and stem-like cells in ENU-glioma malignant process
por: Bulnes, Susana, et al.
Publicado: (2018)

Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma
por: Luo, Lin, et al.
Publicado: (2022)

Challenges in, and recommendations for, hyperspectral imaging in ex vivo malignant glioma biopsy measurements
por: Walke, Anna, et al.
Publicado: (2023)

Tumor Metabolism of Malignant Gliomas
por: Ru, Peng, et al.
Publicado: (2013)

Gene therapy for malignant glioma
por: Okura, Hidehiro, et al.
Publicado: (2014)

Modeling phenotypes of malignant gliomas
por: Sampetrean, Oltea, et al.
Publicado: (2017)

Theranostic Nanomedicine for Malignant Gliomas
por: d'Angelo, Michele, et al.
Publicado: (2019)

CHL1 Is Expressed and Functions as a Malignancy Promoter in Glioma Cells
por: Yang, Zhai, et al.
Publicado: (2017)

Telemetric monitoring of intracystic pressure with sensor reservoir for recurrent sellar arachnoid cysts
por: Jannelli, Gianpaolo, et al.
Publicado: (2022)

Bone Morphogenetic Protein 4 Targeting Glioma Stem-Like Cells for Malignant Glioma Treatment: Latest Advances and Implications for Clinical Application
por: Nayak, Sonali, et al.
Publicado: (2020)

MicroRNAs in Human Malignant Gliomas
por: Mizoguchi, Masahiro, et al.
Publicado: (2012)

Targeted therapy in the treatment of malignant gliomas
por: Lukas, Rimas V, et al.
Publicado: (2009)

New developments in surgery of malignant gliomas
por: Vranic, Andrej
Publicado: (2011)

Treatment of malignant glioma using hyperthermia
por: Sun, Jiahang, et al.
Publicado: (2013)

The Controversial Role of Microglia in Malignant Gliomas
por: Wei, Jun, et al.
Publicado: (2013)

Role of MicroRNAs in Malignant Glioma
por: Wang, Bao-Cheng, et al.
Publicado: (2015)

Targeting immune checkpoints in malignant glioma
por: Zhang, Xuhao, et al.
Publicado: (2016)

Corrigendum: Theranostic Nanomedicine for Malignant Gliomas
por: d'Angelo, Michele, et al.
Publicado: (2020)

Polymeric Nanoparticles for the Treatment of Malignant Gliomas
por: Mahmoud, Basant Salah, et al.
Publicado: (2020)

Current Immunotherapeutic Approaches for Malignant Gliomas
por: Han, Myung-Hoon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l54md3vbq7f5don0rfb5qocjsg